Albayati , D.I.R. and Oday Hatem, D.A. 2025. Effectiveness and Safety of Ocrelizumab in Primary Progressive Multiple Sclerosis among Iraqi Patients. World of Medicine : Journal of Biomedical Sciences. 2, 3 (Mar. 2025), 86–91.